Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
Artificial Limbs Manufacturing Corporation Of India (alimco)
Progress
Quantity
803200
Category
Title1
Bid Type
Two Packet Bid
N/a announces a tender for Title1, Title2, Title3, Title4, Title5, Title6, Title7, Title8, Title9, Title10, Title11, Title12, Title13, Title14, Title15, Title16, Title17, Title18 in BANGALORE, KARNATAKA. Quantity: 803200. Submission Deadline: 09-06-2025 10: 00: 00. Last date to apply is approaching fast!
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Artificial Limbs Manufacturing Corporation Of India (alimco)
Hemwati Nandan Bahuguna Garhwal University Uttarakhand
Pauri Garhwal, UTTARAKHAND
Central Institute Of Psychiatry (cip)
RANCHI, JHARKHAND
Indian Army
Rangareddi, TELANGANA
Indian Army
JALPAIGURI, WEST BENGAL
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | Paracetamol Tablet | 200,000 | pieces | sharath24 | 15 |
| 2 | Title2 | Levocetrizine Tablet | 40,000 | pieces | sharath24 | 15 |
| 3 | Title3 | Albendazole Tablet | 40,000 | pieces | sharath24 | 15 |
| 4 | Title4 | Ferrous Sulphate Tab | 40,000 | pieces | sharath24 | 15 |
| 5 | Title5 | Hydrogen Peroxide 400 ML | 2,000 | pieces | sharath24 | 15 |
| 6 | Title6 | Bleaching Powder | 1,200 | pieces | sharath24 | 15 |
| 7 | Title7 | Ranitidine 150 MG Tab | 40,000 | pieces | sharath24 | 15 |
| 8 | Title8 | Omeprazole 20 | 40,000 | pieces | sharath24 | 15 |
| 9 | Title9 | Ondasatron 4mf Tab | 40,000 | pieces | sharath24 | 15 |
| 10 | Title10 | ORS 4.5 g | 40,000 | pieces | sharath24 | 15 |
| 11 | Title11 | Zinc Sulphate 20 MG Tab | 30,000 | pieces | sharath24 | 15 |
| 12 | Title12 | Dyclyamine Tab 10 Mg | 40,000 | pieces | sharath24 | 15 |
| 13 | Title13 | Salbutamol 2 MG | 20,000 | pieces | sharath24 | 15 |
| 14 | Title14 | Ascorbic Acid 500 MG | 20,000 | pieces | sharath24 | 15 |
| 15 | Title15 | Calcium Carbonate 500 MG | 20,000 | pieces | sharath24 | 15 |
| 16 | Title16 | Cholecalciferol 60K UI | 20,000 | pieces | sharath24 | 15 |
| 17 | Title17 | Pyridoxine Hydrochloride | 20,000 | pieces | sharath24 | 15 |
| 18 | Title18 | B Complex | 150,000 | pieces | sharath24 | 15 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
09-Jun-2025, 10:00 am
Opening Date
09-Jun-2025, 10:30 am
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | AISHWARYA AGENCIES Under PMA | - | 07-06-2025 13:57:54 | Disqualified |
| 2 | GULAB MEDICOSE Under PMA | - | 07-06-2025 09:58:20 | Disqualified |
| 3 | VASUDEVA MEDICARE Under PMA | - | 06-06-2025 18:23:04 | Qualified |
| 4 | VEE ENTERPRISES Under PMA | - | 07-06-2025 12:40:56 | Qualified |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | VEE ENTERPRISES Under PMA | ₹29,43,700 | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl |
| L2 | VASUDEVA MEDICARE Under PMA | ₹31,11,660 | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl |
Please sign in or create an account to view contract details and download result documents.
Key insights about KARNATAKA tender market
The eligibility requirements include being a registered entity with valid certifications in pharmaceutical supply. Bidders must also possess requisite experience and financial stability to ensure they can meet the tender's demands adequately. Compliance with local regulations is essential, and bidders should also demonstrate capability through previous supply contracts related to medical products.
Bidders must provide several critical certificates for participation. This includes valid Drug Licenses, Manufacturing Approvals, and any necessary quality assurance certifications. Compliance with the Drug and Cosmetics Act is also mandatory. Documentation must be submitted in specified formats detailed in the procurement guidelines, ensuring verification processes can proceed smoothly.
To participate in the tender, all documents must be submitted according to the designated submission process outlined in the tender notice. Applicants are required to compile both technical and financial proposals and upload them in accepted digital formats. Timeliness is crucial as late submissions may result in disqualification from the bidding process.
The evaluation and selection process will involve a detailed review of submitted documents based on technical capabilities and financial offers. Bidders will undergo scoring based on quality assurance criteria and adherence to specified requirements. The selection committee will give preference to submissions that offer the best value-for-money while meeting all compliance standards.
Yes, this tender particularly encourages participation from Micro, Small, and Medium Enterprises (MSEs) by offering benefits such as relaxed eligibility criteria and potential financial incentives. Additionally, the initiative aligns with the 'Make in India' policy, promoting local industries and ensuring an equitable opportunity for all participants in the tendering process.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS